4//SEC Filing
Schallenberger Mark A. 4
Accession 0001235802-23-000098
CIK 0001453593other
Filed
Aug 16, 8:00 PM ET
Accepted
Aug 17, 5:20 PM ET
Size
8.1 KB
Accession
0001235802-23-000098
Insider Transaction Report
Form 4
Schallenberger Mark A.
Chief Operations Officer
Transactions
- Award
Stock Option (right to buy)
2023-08-15+135,501→ 135,501 totalExercise: $1.20Exp: 2033-08-15→ Common Stock (135,501 underlying) - Award
Common Stock
2023-08-15+116,144→ 205,144 total
Footnotes (3)
- [F1]These shares will vest and be issued with respect to 29,036 shares on each of August 15, 2024, August 15, 2025, August 15, 2026 and August 15, 2027 pursuant to a restricted stock unit granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan, conditioned upon the Reporting Person remaining an employee of Xtant through the vesting date.
- [F2]Includes 116,144 shares to be issued upon vesting pursuant to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan and 89,000 shares to be issued upon vesting pursuant to a restricted stock award granted under the Xtant Medical Holdings, Inc. Amended and Restated 2018 Equity Incentive Plan, all conditioned upon the Reporting Person remaining an employee of Xtant through the vesting dates.
- [F3]This option vests with respect to 33,875 shares on August 15, 2024 and with respect to the remaining 75% of such shares over the three-year period thereafter in 12 as nearly equal as possible quarterly installments, conditioned upon the Reporting Person remaining an employee of Xtant through the vesting date.
Documents
Issuer
Xtant Medical Holdings, Inc.
CIK 0001453593
Entity typeother
Related Parties
1- filerCIK 0001960742
Filing Metadata
- Form type
- 4
- Filed
- Aug 16, 8:00 PM ET
- Accepted
- Aug 17, 5:20 PM ET
- Size
- 8.1 KB